Zobrazeno 1 - 10
of 18
pro vyhledávání: '"E. A. Cherkashova"'
Autor:
D. D. Namestnikova, I. L. Gubskiy, D. I. Salikhova, G. E. Leonov, K. K. Sukhinich, P. A. Melnikov, D. A. Vishnevskiy, E. A. Cherkashova, A. N. Gabashvili, T. B. Bukharova, V. V. Burunova, T. Kh. Fatkhudinov, V. P. Chekhonin, L. V. Gubsky, S. L. Kiselev, D. V. Goldstein, K. N. Yarygin
Publikováno v:
Vestnik Transplantologii i Iskusstvennyh Organov, Vol 21, Iss 1, Pp 153-164 (2019)
Aim. Neural progenitor cells (NPC) are used for the development of cell therapies of neurological diseases. Their stereotaxic transplantation in the middle cerebral artery occlusion (MCAO) model imitating ischemic stroke results in symptom aleviation
Externí odkaz:
https://doaj.org/article/7c718b2681274f22840ceec0d1496570
Autor:
E. A. Cherkashova, D. D. Namestnikova, I. L. Gubskiy, V. A. Revkova, K. K. Sukhinich, P. A. Mel’nikov, V. P. Chekhonin, L. V. Gubsky, K. N. Yarygin
Publikováno v:
Bulletin of Experimental Biology and Medicine. 173:514-518
Autor:
E. A Cherkashova, D. I Salikhova, D. D Namestnikova, G. E Leonov, I. L Gubskiy, A. A Solovieva, G. B Akopyan, V. V Kurilo, M. P Nikitina, T. Kh Fatkhudinov, V. P Chekhonin, L. V Gubskiy, K. N Yarygin, T. B Bukharova, D. V Goldshtein
Publikováno v:
Genes & Cells. 15:80-84
Transplantation of various types of stem cells as a possible therapy for stroke has been tested for years and the results are promising. Recently, most researchers are inclined to assume that the therapeutic effect of stem cell therapy is based on th
Autor:
P. A. Mel’nikov, E A Cherkashova, I. L. Gubskiy, Veronica A Revkova, Leonid V. Gubsky, K. K. Sukhinich, A. N. Gabashvili, D. D. Namestnikova, Vladimir P. Baklaushev, Konstantin N. Yarygin
Publikováno v:
NEUROSCIENCE FOR MEDICINE AND PSYCHOLOGY.
Autor:
T. Kh. Fatkhudinov, Konstantin N. Yarygin, I. L. Gubskiy, Georgy Leonov, Diana Salikhova, Daniil A. Vishnevskiy, Vladimir P. Chekhonin, V. V. Burunova, K. K. Sukhinich, P. A. Mel’nikov, A. N. Gabashvili, D. V. Goldstein, E A Cherkashova, S. L. Kiselev, D. D. Namestnikova, Leonid V. Gubsky, T. B. Bukharova
Publikováno v:
Vestnik Transplantologii i Iskusstvennyh Organov, Vol 21, Iss 1, Pp 153-164 (2019)
Aim. Neural progenitor cells (NPC) are used for the development of cell therapies of neurological diseases. Their stereotaxic transplantation in the middle cerebral artery occlusion (MCAO) model imitating ischemic stroke results in symptom aleviation
Autor:
Gevorg Akopyan, Konstantin N. Yarygin, Diana Salikhova, Victoria Mokrousova, Natalia Bulatenco, D. V. Gol’dshtein, D. D. Namestnikova, T. B. Bukharova, Andrey Elchaninov, Maria Nikitina, Timur Fatkhudinov, Liudmila M. Mikhaleva, Georgy Leonov, E A Cherkashova, Vladimir P. Chekhonin, A. V. Makarov, I. L. Gubskiy, Konstantin Midiber
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 9
International Journal of Molecular Sciences, Vol 22, Iss 4694, p 4694 (2021)
Volume 22
Issue 9
International Journal of Molecular Sciences, Vol 22, Iss 4694, p 4694 (2021)
Transplantation of various types of stem cells as a possible therapy for stroke has been tested for years, and the results are promising. Recent investigations have shown that the administration of the conditioned media obtained after stem cell culti
Autor:
I. L. Gubskiy, E A Cherkashova, Natalia Bulatenco, D. V. Gol’dshtein, T. B. Bukharova, Georgy Leonov, Konstantin Midiber, Timur Fatkhudinov, Konstantin N. Yarygin, Diana Salikhova, Liudmila M. Mikhaleva, Gevorg Akopyan, Vladimir P. Chekhonin, A. V. Makarov, Victoria Mokrousova, D. D. Namestnikova, Maria Nikitina, Andrey Elchaninov
Background: Stem cell secretomes hold great promise for regenerative medicine. This study is focused on the secretome-mediated neuroprotective effects of the human induced pluripotent stem cell-derived neuronal and glial progenitor cells. Therapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7a662e81206a65992540a46f41f5fa4
https://doi.org/10.21203/rs.3.rs-49227/v2
https://doi.org/10.21203/rs.3.rs-49227/v2
Autor:
I L Gubskii, Georgy Leonov, T. B. Bukharova, A A Solov'eva, Konstantin N. Yarygin, E A Cherkashova, L V Gubskii, D. D. Namestnikova, D V Goldstein
Publikováno v:
Bulletin of experimental biology and medicine. 168(4)
The use of induced pluripotent stem cells (IPSC) is a promising approach to the therapy of CNS diseases. The undeniable advantage of IPSC technology is the possibility of obtaining practically all types of somatic cells for autologous transplantation
Autor:
Konstantin N. Yarygin, L. V. Gubskiy, K. K. Sukhinich, I. L. Gubskiy, D. D. Namestnikova, R. T. Tairova, E A Cherkashova
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 118(9. Vyp. 2)
The literature review addresses the use of stem cells (SC) in ischemic stroke (IS). Part 1 of the paper overviews the results of experimental animal studies. Characteristics of different SC types and results of their studies in experimental models of
Autor:
I. L. Gubskiy, E A Cherkashova, K. K. Sukhinich, Konstantin N. Yarygin, Georgy Leonov, Leonid V. Gubsky, Alexander G. Majouga, D. D. Namestnikova
Publikováno v:
Biomedicines, Vol 8, Iss 613, p 613 (2020)
Biomedicines
Biomedicines
Cell therapy of neurological diseases is gaining momentum. Various types of stem/progenitor cells and their derivatives have shown positive therapeutic results in animal models of neurological disorders and in clinical trials. Each tested cell type p